Literature DB >> 8285547

Outcome of biliary tract surgery in unknown cirrhotics: a case-control study.

S Hamid1, M Siddiqui, W Jafri, H Shah, H Khan, M Ahmed.   

Abstract

The substantial risk of biliary surgery in patients with liver cirrhosis may be reduced by preoperative preparation but the problem of the unknown cirrhotic remains. We studied 18 patients found incidentally to have cirrhosis at surgery. The perioperative complications and the outcome in these patients was compared with 18 non-cirrhotic patients, computer matched for age and sex, undergoing the same operations. Mean blood loss at operation was 324 ml (SD 218.1 ml) in the cirrhotic group and 105 ml (SD 74.7 ml) in the control group (P < 0.01). The postoperative complication rate was 38% in cirrhotics, but zero in controls (P < 0.01). The length of hospital stay was significantly increased in the cirrhotic group (P < 0.01). There was no mortality in either group. The incidental finding of cirrhosis at biliary surgery is associated with increased peroperative bleeding and increased morbidity. There is no increase in mortality in such patients.

Entities:  

Mesh:

Year:  1993        PMID: 8285547      PMCID: PMC2497998     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  12 in total

1.  Increased incidence of cholelithiasis in Laënnec's cirrhosis. A postmortem evaluation of pathogenesis.

Authors:  P Nicholas; P A Rinaudo; H O Conn
Journal:  Gastroenterology       Date:  1972-07       Impact factor: 22.682

2.  Postmortem study of the frequency of gallstones in patients with cirrhosis of the liver.

Authors:  I A Bouchier
Journal:  Gut       Date:  1969-09       Impact factor: 23.059

3.  Improving survival in patients with cirrhosis undergoing major abdominal operations.

Authors:  K R Sirinek; R R Burk; M Brown; B A Levine
Journal:  Arch Surg       Date:  1987-03

4.  Therapeutic options for biliary tract disease in advanced cirrhosis.

Authors:  G V Aranha; D Kruss; H B Greenlee
Journal:  Am J Surg       Date:  1988-03       Impact factor: 2.565

5.  Acute cholecystitis in the diabetic. A case-control study of outcome.

Authors:  M S Hickman; W H Schwesinger; C P Page
Journal:  Arch Surg       Date:  1988-04

6.  Cholecystectomy in patients with mild cirrhosis. A more favorable situation.

Authors:  K Kogut; T Aragoni; N B Ackerman
Journal:  Arch Surg       Date:  1985-11

7.  Surgical management of gallstones in cirrhotic patients.

Authors:  D Castaing; D Houssin; J Lemoine; H Bismuth
Journal:  Am J Surg       Date:  1983-09       Impact factor: 2.565

8.  Cholecystectomy in patients with cirrhosis. A surgical challenge.

Authors:  R S Bloch; R D Allaben; A J Walt
Journal:  Arch Surg       Date:  1985-06

9.  Incidence of cholelithiasis among patients with cirrhosis and portal hypertension.

Authors:  H V Steinberg; W W Beckett; J L Chezmar; W E Torres; F B Murphy; M E Bernardino
Journal:  Gastrointest Radiol       Date:  1988-10

10.  Natural history of cholelithiasis in patients with alcoholic cirrhosis (cholelithiasis in cirrhotic patients).

Authors:  G Dunnington; E Alfrey; R Sampliner; F Kogan; C Putnam
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

View more
  3 in total

Review 1.  Laparoscopic or open cholecystectomy in cirrhosis: a systematic review of outcomes and meta-analysis of randomized trials.

Authors:  Jerome M Laurence; Peter D Tran; Arthur J Richardson; Henry C C Pleass; Vincent W T Lam
Journal:  HPB (Oxford)       Date:  2012-01-18       Impact factor: 3.647

2.  Laparoscopic cholecystectomy in cirrhotic patients with symptomatic cholelithiasis: a case-control study.

Authors:  Jorge Marcelo Padilla Mancero; Luiz Augusto Carneiro D'Albuquerque; Adriano Miziara Gonzalez; Frans Ivan Serpa Larrea; Adavio de Oliveira e Silva
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

3.  Laparoscopic cholecystectomy in cirrhotic patients.

Authors:  Abdul Razaque Shaikh; Ambreen Muneer
Journal:  JSLS       Date:  2009 Oct-Dec       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.